Consensus IRADIMED CORPORATION

Equities

IRMD

US46266A1097

Real-time Estimate Cboe BZX Other stock markets 03:43:15 2024-05-06 pm EDT			5-day change	1st Jan Change
43.14 ^USD	-3.49%		+6.31%	-8.41%

May. 02	Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024
May. 02	Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M	MT

Evolution of the average Target Price on IRADIMED CORPORATION

Price target over the last 5 years

History of analyst recommendation changes

a9e75e929946797b374.ErM88bW20eOV9P7VpaMG2bPSSdi-wMTxQR0MdZqRiOk.W_hNkOfzg6XiwayGx8ZjssOmMJLImJC9NylbJfbwpZ0r33iz9OmirNe4yg~52743e7f0a8e41d9f402cc29193c7297

Analyst Recommendations on IRADIMED CORPORATION

Roth Capital Adjusts IRadimed's Price Target to $42 From $36, Maintains Buy Rating	21-11-02	MT
IRADIMED : Roth Capital Adjusts iRadimed's Price Target to $36 from $32, Keeps Buy Rating	21-08-02	MT